Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2014
At a glance
- Drugs Melanoma vaccine (Primary) ; Granulocyte macrophage colony stimulating factor; Interferon alpha-2b
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 16 Dec 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 08 May 2009 Actual patient number (23) added as reported by ClinicalTrials.gov record.